topic-hub/
12 pages · Updated June 15, 2026
Pages
- topic-hub/glp-1-drugs-the-obesity-pipeline-race-and-whats-next.html
- topic-hub/biopharma-people-moves-ceo-changes-executive-hires-board-positions.html
- topic-hub/biotech-venture-funding-whos-raising-and-where-the-money-is-going.html
- Drug pricing and the IRA: Tracking the government's negotiation power
- Antibody-drug conjugates: The next wave of targeted cancer drugs
- Cell and gene therapy manufacturing: Scaling the next frontier
- AI drug discovery: News, analysis and interviews
- China biotech: Licensing deals and the Biosecure Act
- CRISPR and gene editing: The push for in vivo therapies
- FDA policy and drug approvals: What’s changing for biopharma
- Biopharma M&A and dealmaking: Who’s buying and why
- Biotech IPOs: Tracking the market for new public offerings